Research Large Grants Programme Opportunity
Oracle HNCUK announce 2025 Research Large Grants Programme – Applications now closed!
Oracle Head & Neck Cancer UK in partnership with a family foundation, is excited to announce its Research Large Grants Programme for 2025. We’re offering up to £300,000 over three years to support innovative, hypothesis-driven research projects that address critical challenges in head and neck cancer.
Programme Goals:
- Support impactful pre-clinical research that advances understanding, prevention, early detection, or treatment of head and neck cancers.
- Foster ground breaking work, including but not limited to laboratory-based (wet lab) and bioinformatics/in silico research approaches.
- Drive innovation with a clear potential to improve patient outcomes and experiences.
- Encourage interdisciplinary collaboration and support research that can lead to real-world applications.
Eligibility and Scope
- Open to principal investigators affiliated with UK universities, research institutes, or NHS organisations.
- Hypothesis-driven research in any area of head and neck cancer is eligible, with no restrictions on specific research topics.
- Projects involving clinical trials or post-clinical activities are excluded.
Evaluation Criteria
Proposals will be evaluated based on:
- Scientific Merit: The quality, rigour, and novelty of the research approach.
- Impact Potential: The likelihood of delivering tangible improvements in head and neck cancer outcomes or patient care.
Funding Details
- Award Amount: Up to £300,000 over three years.
- Covers research staff salaries, consumables, and equipment.
Application Timeline
- Call Opens: December 17, 2024
- Submission Deadline: Midnight, February 17, 2025 (now closed)
- Funding Decisions Announced: by May 2025
How to Apply
Applications must include:
- PPI (Patient and Public Involvement) Plan: Demonstrating how patient input informs the research.
- Impact Plan: Highlighting the anticipated benefits and the path to practical application.
We look forward to receiving your proposals and supporting research that has the potential to transform outcomes for head and neck cancer patients.
Applications should be submitted by midnight, February 17, 2025 using the form below. For more information, please contact us with any questions.
Yours sincerely,
New applicant registration
Existing applicant
2 Minutes to Save Your Life: Oracle Launches HeadNeckCheck Campaign for Make Sense Week
This Make Sense Week (15-20 September), the European-wide head and neck cancer awareness initiative, Oracle Head & Neck Cancer UK, is championing both prevention and early detection – recognising that stopping cancer before it starts is just as vital as catching it early. Two Ways to Fight Cancer This Week Prevention Today: Head and neck…
Leadership update
After four successful years as CEO, Tamara Kahn has transformed Oracle into a respected national voice for head and neck cancer patients. She established a national presence, created a four-pillar RACE strategy (Research, Awareness, Collaboration and Patient/Community Engagement) and built strong policy influence. With these foundations now firmly in place, Tamara will transition from her…
Finding Light in Adversity: Seven inspiring stories through head and neck cancer
A new collection of patient stories from Oracle Head and Neck Cancer UK reveals how individuals facing head and neck cancer have discovered unexpected sources of strength, purpose and even joy during their treatment and recovery. The seven contributors share remarkably similar themes despite their unique journeys. Almost all emphasise the power of maintaining a…
NHS to fast-track patients with head and neck cancer into cancer vaccine trial
Patients with advanced head and neck cancers in England will be fast-tracked into a trial of a new cancer vaccine, as the NHS expands its world-leading trial ‘match-making’ service. The investigational cancer vaccine uses mRNA technology to help the immune system recognise and kill cancer cells containing human papillomavirus proteins. More than 100 patients with advanced head…
World Head and Neck Cancer Awareness Day 2025: The HPV Vaccine Could Save Your Life
27th July 2025 This World Head and Neck Cancer Awareness Day, Oracle Head and Neck Cancer UK has a simple but urgent message: HPV vaccination saves lives. With HPV-related head and neck cancers having doubled in the past 20 years, the charity is using today to remind the public that these devastating cancers are preventable…
Data from the National Disease Registration Service on HPV associated and HPV independent oropharyngeal squamous cell carcinoma
The Get Data Out Programme from the National Disease Registration Service (NDRS), part of NHS England, has published statistics on incidence, routes to diagnosis and treatment for patients diagnosed with oropharyngeal cancer in England by human papillomavirus (HPV) status. To our knowledge this is the first time data on oropharyngeal cancer by HPV status has…
Join Us for an Evening of Research, Impact, and Conversation
Research & Impact EveningDate: Monday 28th April 2025Time: 6:00 PM – 8:30 PMVenue: Skyline, Tower Suites, 100 Minories, London EC3N 1JY A Celebration of Research Join us for a meaningful and action-focused evening where we’ll be diving into some of the big conversations around head and neck cancer – especially those linked to HPV (human…
What the Rare Cancers Bill Means for Head & Neck Cancer
14 March marked a crucial moment for research into rare cancers, as the Rare Cancers Bill took another significant step toward becoming law! Dr. Scott Arthur, a Labour MP, introduced this legislation in Parliament to drive much-needed research into cancers affecting fewer than 1 in 2000 people in the UK – including many types of…
Theatre Meets Healthcare: Breaking Barriers in Cancer Conversations
In Leicester, theatre is transforming how Black communities talk about cancer. Oracle Head & Neck Cancer UK, alongside Theatre Sans Frontières, is using interactive Forum Theatre to tackle stigma, improve healthcare conversations, and break down cultural barriers. Actors bring real-life cancer diagnosis experiences to the stage – but the audience isn’t just watching. They step in, suggest changes, and…
Jamie Theakston Announces He is Cancer-Free After Laryngeal Cancer Treatment
Heart Breakfast’s much-loved presenter, Jamie Theakston, has shared the incredible news that he is now cancer free! After completing treatment for stage one laryngeal cancer – cancer of the voice box (larynx), Jamie made his highly anticipated return to the airwaves today, reuniting with listeners and co-hosts alike. Diagnosed in September 2024, Jamie initially thought…
Help Beat Head and Neck Cancer
Oracle Head & Neck Cancer UK is a registered charity in England and Wales (1142037), and in Scotland (SC052790).
Registered as a company limited by guarantee in England and Wales (7125497). Registered address: 80 Coombe Road, New Malden KT3 4QS.